21 octubre 2015
Researchers will launch the first Phase 1 human trials of a drug — derived from the female hormone estrogen — that may help patients with severe bleeding survive long enough to get to appropriate medical care. The drug may have a profound effect on an individual’s ability to survive major blood loss.
http://www.sciencedaily.com/releases/2015/10/151021151811.htm
